Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study.

[1]  P. Nuciforo,et al.  Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  D. Longley,et al.  Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[3]  C. Ulrich,et al.  Clinicopathologic and Racial/Ethnic Differences of Colorectal Cancer Among Adolescents and Young Adults , 2019, Clinical and translational gastroenterology.

[4]  E. Riboli,et al.  Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study , 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[5]  H. Tunsjø,et al.  Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients , 2019, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  Paul Theodor Pyl,et al.  Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer , 2019, Nature Medicine.

[7]  N. Cho,et al.  Prognostic Impact of Fusobacterium nucleatum Depends on Combined Tumor Location and Microsatellite Instability Status in Stage II/III Colorectal Cancers Treated with Adjuvant Chemotherapy , 2018, Journal of pathology and translational medicine.

[8]  W. Garrett,et al.  Fusobacterium nucleatum — symbiont, opportunist and oncobacterium , 2018, Nature Reviews Microbiology.

[9]  J. Böhm,et al.  The ColoCare Study: A Paradigm of Transdisciplinary Science in Colorectal Cancer Outcomes , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[10]  J. Böhm,et al.  Body Fatness, Adipose Tissue Compartments, and Biomarkers of Inflammation and Angiogenesis in Colorectal Cancer: The ColoCare Study , 2018, Cancer Epidemiology, Biomarkers & Prevention.

[11]  Yan Shi,et al.  Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[12]  R. Steele,et al.  A review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK , 2018, BMC Cancer.

[13]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[14]  Linfang Li,et al.  A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of Fusobacterium Nucleatum to Probiotics Populations, Based on Their Antagonistic Effect. , 2018, Clinical chemistry.

[15]  A. Nakajima,et al.  Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity , 2018, Gut.

[16]  David A. Drew,et al.  Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor Tissue , 2017, JAMA oncology.

[17]  C. Dutta,et al.  Geography, Ethnicity or Subsistence-Specific Variations in Human Microbiome Composition and Diversity , 2017, Front. Microbiol..

[18]  H. Qin,et al.  Mucosa-associated microbiota signature in colorectal cancer , 2017, European Journal of Clinical Microbiology & Infectious Diseases.

[19]  Soumen Roy,et al.  Microbiota: a key orchestrator of cancer therapy , 2017, Nature Reviews Cancer.

[20]  M. Meyerson,et al.  Fusobacterium nucleatum in Colorectal Carcinoma Tissue According to Tumor Location , 2016, Clinical and translational gastroenterology.

[21]  Antonio Gasbarrini,et al.  Antibiotics as deep modulators of gut microbiota: between good and evil , 2016, Gut.

[22]  Hiromu Suzuki,et al.  Association of Fusobacterium nucleatum with clinical and molecular features in colorectal serrated pathway , 2015, International journal of cancer.

[23]  Mingyang Song,et al.  Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis , 2015, Gut.

[24]  C. Huttenhower,et al.  Fusobacterium nucleatum and T Cells in Colorectal Carcinoma. , 2015, JAMA oncology.

[25]  Hermann Brenner,et al.  Colorectal cancer , 2014, The Lancet.

[26]  Se Jin Song,et al.  The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.

[27]  M. Toyota,et al.  Fusobacterium in colonic flora and molecular features of colorectal carcinoma. , 2014, Cancer research.

[28]  J. Hurley,et al.  The molecular genetics of colorectal cancer , 2013, Frontline Gastroenterology.

[29]  M. Meyerson,et al.  Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. , 2013, Cell host & microbe.

[30]  R. Sandler,et al.  Fusobacterium Is Associated with Colorectal Adenomas , 2013, PloS one.

[31]  D. Kobayashi,et al.  Changes of the Intestinal Microbiota, Short Chain Fatty Acids, and Fecal pH in Patients with Colorectal Cancer , 2013, Digestive Diseases and Sciences.

[32]  P. Zilm,et al.  A proteomic investigation of Fusobacterium nucleatum alkaline-induced biofilms , 2012, BMC Microbiology.

[33]  B. Birren,et al.  Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. , 2012, Genome research.

[34]  Richard A. Moore,et al.  Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.

[35]  J. Burgess,et al.  Improvement of phylum- and class-specific primers for real-time PCR quantification of bacterial taxa. , 2011, Journal of microbiological methods.

[36]  V. Uitto,et al.  Intracellular replication of fusobacteria requires new actin filament formation of epithelial cells   , 2008, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.